{
    "clinical_study": {
        "@rank": "43705", 
        "arm_group": [
            {
                "arm_group_label": "Off-pump coronary artery bypass graft", 
                "description": "Patients operated on with off-pump coronary artery bypass graft, beating heart surgery."
            }, 
            {
                "arm_group_label": "Mini extracorporeal circulation bypass", 
                "description": "Patients operated on with mini extracorporeal circulation bypass. A modified extracorporeal system."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators aimed to evaluate the clinical results and the inflammatory response of\n      the minimal extracorporeal circulation system (MECC) Compared with off-pump coronary\n      revascularization (OPCABG).\n\n      This is a randomized and prospective study in 230 patients with indications for coronary\n      surgery, with 113 patients in the OPCABG group and 117 in the MECC group. The endpoints were\n      the clinical and biochemical results, intra-operative outcomes and the determination of 19\n      inflammatory circulating markers, 17 of them for the first time analyzed comparing both\n      techniques."
        }, 
        "brief_title": "Coronary Bypass Grafting With Minimal Extracorporeal Circulation System Versus Off-pump Coronary Surgery", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Indication for coronary surgery established on the basis of current published\n             guidelines\n\n        Exclusion Criteria:\n\n          -  Documented preoperative systemic proinflammatory status and/or steroid administration\n             within 6 months before surgery.\n\n          -  Coexistence of a cardiomyopathy different than coronary artery disease that precise\n             surgical treatment.\n\n          -  Left ventricle ejection fraction of 40% or less.\n\n          -  Treatment with erythropoietin (EPO) three months before the intervention\n\n          -  Hematocrit less than 35% the day prior to the procedure\n\n          -  Redo surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "230 patients with indication for coronary surgery established on the basis of current\n        published guidelines. All patients provided written consent to enter the study."
            }
        }, 
        "enrollment": {
            "#text": "230", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02118025", 
            "org_study_id": "MECC-1", 
            "secondary_id": "MECC-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Off-pump coronary artery bypass graft", 
                "description": "Patients operated with the heart beating, without heart arrest.", 
                "intervention_name": "Off-pump coronary artery bypass graft", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Mini extracorporeal circulation bypass", 
                "description": "Patients operated with a modified extracorporeal circulation system", 
                "intervention_name": "Mini extracorporeal circulation bypass", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Off-pump bypass graft surgery", 
            "Mini extracorporeal circulation bypass surgery"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Barcelona", 
                    "country": "Spain", 
                    "zip": "08026"
                }, 
                "name": "Hospital de la Santa Creu i Sant Pau"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "2", 
        "official_title": "Prospective Randomized Comparison of Coronary Bypass Grafting With Minimal Extracorporeal Circulation System (MECC) Versus Off-pump Coronary Surgery. New Insights Into Inflammatory Cytokines.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Number of Participants with Adverse Events, e.g, renal failure, atrial fibrillation, acute myocardial infarct, stroke, redo surgery, death.", 
            "measure": "Clinical outcomes", 
            "safety_issue": "Yes", 
            "time_frame": "within the first 30 days (plus or minus 3 days) after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02118025"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Determination of increase over the first 48 hours after the operation of plasma levels of 19 circulating markers of inflammatory response. The levels of inflammatory markers are measured in pg / mL and subsequently, the increase over the 48 hours is determined with the area under the curve.", 
                "measure": "Determination of increase over the first 48 hours of plasma levels of 19 circulating markers of inflammatory response.", 
                "safety_issue": "Yes", 
                "time_frame": "Area Under the Concentration-Time Curve (AUC 0-48 hours)"
            }, 
            {
                "description": "Changes in creatine kinase  levels, troponin levels, glucose, leukocytes, platelets, hemoglobin and hematocrit levels. From basal point to 48 hours time after surgery.", 
                "measure": "Biochemical outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "Within the first 30 days (plus or minus 3 days) after surgery"
            }, 
            {
                "description": "Number of distal anastomosis.", 
                "measure": "Operative results", 
                "safety_issue": "Yes", 
                "time_frame": "Within the first 30 days (plus or minus 3 days) after surgery"
            }, 
            {
                "description": "Type of grafts used.", 
                "measure": "Operative results", 
                "safety_issue": "Yes", 
                "time_frame": "Within the first 30 days (plus or minus 3 days) after surgery"
            }, 
            {
                "description": "time until removal of mechanical respiratory support", 
                "measure": "Operative results", 
                "safety_issue": "Yes", 
                "time_frame": "Within the first 30 days (plus or minus 3 days) after surgery"
            }, 
            {
                "description": "Time at intensive care unit (days)", 
                "measure": "Operative results", 
                "safety_issue": "Yes", 
                "time_frame": "Within the first 30 days (plus or minus 3 days) after surgery"
            }, 
            {
                "description": "Total hospitalization time (days)", 
                "measure": "Operative results", 
                "safety_issue": "Yes", 
                "time_frame": "Within the first 30 days (plus or minus 3 days) after surgery"
            }
        ], 
        "source": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2006", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}